British Association of Dermatologists Guidelines for Use of Biological Interventions in Psoriasis

C. H. Smith, A. V. Anstey, J. N. Barker, A. D. Burden, R. J. Chalmers, D. Chandler, A. Y. Finlay, C. E. M. Griffiths, K. Jackson, N. J. McHugh, K. E. McKenna, N. Reynolds, Anthony Ormerod

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)486-497
Number of pages11
JournalBritish Journal of Dermatology
Volume153
DOIs
Publication statusPublished - Sep 2005

Keywords

  • biologics
  • efalizumab
  • etanercept
  • guideline
  • infliximab
  • psoriasis
  • PLAQUE-TYPE PSORIASIS
  • FACTOR-ALPHA ANTAGONISTS
  • RANDOMIZED-TRIAL
  • INFLIXIMAB MONOTHERAPY
  • CONSENSUS STATEMENT
  • PUSTULAR PSORIASIS
  • EFALIZUMAB THERAPY
  • HEPATITIS-B
  • ETANERCEPT
  • ARTHRITIS

Cite this

Smith, C. H., Anstey, A. V., Barker, J. N., Burden, A. D., Chalmers, R. J., Chandler, D., Finlay, A. Y., Griffiths, C. E. M., Jackson, K., McHugh, N. J., McKenna, K. E., Reynolds, N., & Ormerod, A. (2005). British Association of Dermatologists Guidelines for Use of Biological Interventions in Psoriasis. British Journal of Dermatology, 153, 486-497. https://doi.org/10.1111/j.1365.2133.2005.06893.x